EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Rosuvastatin Potentiates Gonadotropin-Lowering Effects of Metformin in Postmenopausal Women: A Pilot Study

Robert Krysiak, Karolina Kowalcze, Bogusław Okopień

Pharmacology · 2023

DOI: 10.1159/000528939 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology, 2023. Verfasst von Robert Krysiak und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Katowice, Poland. Hauptthemen laut MEDLINE: Metformin, Hydroxymethylglutaryl-CoA Reductase Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Metformin reduces elevated levels of FSH and LH. In some studies, gonadotroph secretory function was inhibited by statins. The aim of the present study was to investigate whether statin therapy modulates the impact of metformin on hypothalamic-pituitary-gonadal axis activity in postmenopausal women.

Methods

The study population included 60 postmenopausal women with prediabetes, 40 of whom, because of high cardiovascular risk, received rosuvastatin (20–40 mg daily). One group of rosuvastatin-treated women (group A, n = 23) and all statin-naïve patients (group B, n = 20) were matched for age, glucose homeostasis markers, and gonadotropin levels. Over the entire study period (6 months), these women received metformin. The third group (group C) included 17 rosuvastatin-treated women refusing metformin treatment. We assessed baseline and follow-up plasma lipids, glucose homeostasis markers, and concentrations of FSH, LH, thyrotropin, prolactin, adrenocorticotropic hormone (ACTH), insulin-like growth factor-1, estradiol, progesterone, and anti-Müllerian hormone (in selected patients).

Results

Fifty-three women (18 in groups A and B and 17 in group C) completed the study. At study entry, rosuvastatin-treated and statin-naïve women differed in levels of total cholesterol, LDL-cholesterol, and ACTH. In statin-naïve women, metformin reduced FSH levels and tended to reduce LH levels. In rosuvastatin-treated women, metformin decreased FSH and LH levels, and both effects were stronger than in statin-naïve women. Although observed in both groups, the impact on glucose homeostasis markers was more pronounced in individuals not receiving statin therapy. Metformin treatment did not affect circulating levels of lipids, thyrotropin, prolactin, ACTH, insulin-like growth factor-1, estradiol, and anti-Müllerian hormone. In group C, plasma lipids, glucose homeostasis markers, and hormone levels remained at a similar level throughout the study period.

Conclusion

The obtained results indicate that statin therapy may enhance gonadotropin-lowering effects of metformin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminHydroxymethylglutaryl-CoA Reductase InhibitorsHumansFemaleRosuvastatin CalciumProlactinPilot ProjectsInsulin-Like Growth Factor IPostmenopauseAnti-Mullerian HormoneGonadotropinsEstradiolThyrotropinFollicle Stimulating HormoneAdrenocorticotropic HormoneGlucoseLipids

Stichwörter der Autor:innen

HormonesHypothalamic-pituitary-gonadal axisMenopauseMetforminStatins

Substanzen

MetforminRosuvastatin CalciumProlactinInsulin-Like Growth Factor IHydroxymethylglutaryl-CoA Reductase InhibitorsAnti-Mullerian HormoneGonadotropinsEstradiolThyrotropinFollicle Stimulating Hormone

Autor:innen und Institutionen

  • Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Katowice, Poland.
  • Department of Pediatrics in Bytom, School of Health Sciences in Katowice, Medical University of Silesia, Bytom, Poland.

Zitieren

APA

Krysiak, R., Kowalcze, K., & Okopień, B. (2023). Rosuvastatin Potentiates Gonadotropin-Lowering Effects of Metformin in Postmenopausal Women: A Pilot Study. Pharmacology. https://doi.org/10.1159/000528939

Vancouver

Krysiak R, Kowalcze K, Okopień B. Rosuvastatin Potentiates Gonadotropin-Lowering Effects of Metformin in Postmenopausal Women: A Pilot Study. Pharmacology. 2023. doi:10.1159/000528939

BibTeX
@article{Krysiak2023,
  author = {Krysiak, Robert and Kowalcze, Karolina and Okopień, Bogusław},
  title = {Rosuvastatin Potentiates Gonadotropin-Lowering Effects of Metformin in Postmenopausal Women: A Pilot Study},
  journal = {Pharmacology},
  year = {2023},
  doi = {10.1159/000528939}
}
Kostenlos starten →